Macquarie Starts CVS Health (CVS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
- Exclusive-China's DeepSeek developing its own AI chip, sources say
Cowen Raises Price Target on CVS Health (CVS) Following Investor Meetings
June 11, 2015 6:49 AM EDTCowen reiterates an Outperform rating on CVS Health (NYSE: CVS), and raised the price target to $116.00 (from $108.00), following investor meetings with management. Analyst Charles Rhyee says that the addition of OCR allows CVS to provide pharmacy services across the continuum of care.... More
